Sanger Institute Purchases PacBio RS Single-Molecule Sequencer

The company has expanded its early-access program to a “limited number” of sites outside North America. It previously said it is interested in having testing sites in Europe and Asia.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.